[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355594-105":59,"doc-detail-355594-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","uchl5-suppresses-thyroid-carcinoma-progression-via-zranb1-stabilization-and-ferroptosis-regulation","UCHL5 suppresses thyroid carcinoma progression via ZRANB1 stabilization and ferroptosis regulation","","This study investigates the role of UCHL5 in thyroid carcinoma progression, emphasizing tumor-suppressive mechanisms and regulation of ferroptosis. Using multi-omics analyses of TCGA and GEO datasets with clinical validation, the authors applied CRISPR/Cas9 knockout and stable overexpression in thyroid cancer cell models, supported by Co-IP, ubiquitination assays, xenograft studies, and ferroptosis sensitivity tests. Results show UCHL5 downregulation in advanced disease, where loss accelerates growth while restoration suppresses it, mediated through ZRANB1 stabilization and the SLC7A11-GPX4 axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/uchl5-suppresses-thyroid-carcinoma-progression-via-zranb1-stabilization-and-ferroptosis-regulation/355594/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/uchl5-suppresses-thyroid-carcinoma-progression-via-zranb1-stabilization-and-ferroptosis-regulation/355594.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does UCHL5 affect thyroid carcinoma progression?","Question",{"text":112,"@type":113},"UCHL5 is significantly downregulated in advanced thyroid cancers. Knockout accelerates cell proliferation and xenograft tumor growth, while overexpression suppresses both.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the mechanistic link between UCHL5 and ZRANB1?",{"text":117,"@type":113},"UCHL5 directly interacts with ZRANB1 and extends its protein half-life by more than twofold, supported by co-immunoprecipitation findings.",{"name":119,"@type":110,"acceptedAnswer":120},"How is ferroptosis regulated in relation to UCHL5?",{"text":121,"@type":113},"Overexpression of UCHL5 increases sensitivity to erastin, whereas knockout provides protection. This correlates with altered GSH levels, Fe2+ accumulation, and lipid ROS production, along with changes in ZRANB1 and SLC7A11/GPX4 expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355594,1790341322,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","CANCER BIOLOGY & THERAPY 2026, VOL. 27, NO. 1, 2663610  \n[https://doi.org/10.1080/15384047.2026.2663610](https://doi.org/10.1080/15384047.2026.2663610)  \nRESEARCH ARTICLE     \nUCHL5 suppresses thyroid carcinoma progression via ZRANB1 stabilization and ferroptosis regulation  \nWenxia Xiaoa, 1, Yu Dingb, 1, Xuesuo Wub, 1, Fenglian Quea, Baozhi Wangb, Shanshan Hongc and Fenghua Zhangb   \naEndocrinology Department, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; bGeneral Surgery Department, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; cDepartment of Respiratory Medicine, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China  \nABSTRACT  \nObjective: This study investigated the role of UCHL5 in thyroid carcinoma (THCA) progression, focusing on its tumor-suppressive mechanisms and regulation of ferroptosis. Methods: We performed multi-omics analysis of TCGA and GEO datasets and validated the findings using clinical samples. The CRISPR/Cas9-mediated knockout and stable overexpression in THCA cell lines were constructed, followed by comprehensive functional assays including co-immunoprecipitation (Co-IP), ubiquitination analysis, xenograft tumor models, and ferroptosis sensitivity tests using erastin/ferrostatin-1 with BODIPY C11 lipid ROS measurement. Weighted gene co-expression network analysis (WGCNA) was performed to identify hub genes and to analyze associated pathways. Results: Clinical data revealed significant downregulation of UCHL5 in advanced thyroid cancers, particularly in lymph node metastases. UCHL5 knockout markedly accelerated cell proliferation and xenograft tumor growth, while its overexpression suppressed both. Mechanistically, we identified a direct interaction between UCHL5 and ZRANB1 through co-IP, with UCHL5 extending the protein half-life of ZRANB1 by over 2-fold. In ferroptosis regulation, erastin treatment (10 μM) revealed that UCHL5 overexpression enhanced sensitivity, while UCHL5 knockout conferred significant protection, accompanied by altered GSH levels, Fe²⁺ accumulation, and lipid ROS production. Western blot analysis revealed that UCHL5 upregulated ZRANB1 and downregulated SLC7A11/GPX4 expression.  \nConclusion: This study demonstrates that UCHL5 acts as a critical tumor suppressor in thyroid cancer by stabilizing ZRANB1 through deubiquitination and regulating ferroptosis via the SLC7A11-GPX4 axis.  \nARTICLE HISTORY  \nReceived 16 October 2025 Revised 23 March 2026 Accepted 19 April 2026  \nKEYWORDS  \nUCHL5; thyroid cancer; ZRANB1; ferroptosis; deubiquitination  \nIntroduction  \nThyroid carcinoma (THCA) represents the most prevalent endocrine malignancy worldwide, with 586,000 new cases reported in 2020 and an age-standardized incidence rate of 7.7 per 100,000 individuals. 1 Among its histological subtypes, papillary thyroid carcinoma (PTC) accounts for approximately 80% of diagnoses.2 Although 10-y survival exceeds 95% for patients with localized PTC, prognosis worsens significantly upon distant metastasis.3 BRAFV600E mutations are common in recurrent and treatment-refractory THCA, detected in up to 30% of relapsed cases.4,5 Additionally, the Cancer Genome Atlas (TCGA) and other large genomic investigations show that TERT promoter mutations are independent adverse prognostic markers associated with a 7. 1-fold increase in THCA-specific mortality.6 Thus, defining the prognostic utility and therapeutic potential of molecular targets in advanced THCA care is essential for driving the development of precision interventions.  \nCONTACT Fenghua Zhang  1392423881[1@163.com](1@163.com)  General Surgery Department, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Shanshan Hong  [15920336725@163.com](15920336725@163.com)  Department of Respiratory Medicine, the Second Affiliated 1Hospital of Guangzhou Medical University, Guangzhou, China  \nThese authors contributed equally to this work.  ","cbCaidAmP3RVmqRb","https://ap.wps.com/l/cbCaidAmP3RVmqRb","pdf",6799201,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Mechanism and Ferroptosis Regulation\n# Conclusion","[{\"question\":\"How does UCHL5 affect thyroid carcinoma progression?\",\"answer\":\"UCHL5 is significantly downregulated in advanced thyroid cancers. Knockout accelerates cell proliferation and xenograft tumor growth, while overexpression suppresses both.\"},{\"question\":\"What is the mechanistic link between UCHL5 and ZRANB1?\",\"answer\":\"UCHL5 directly interacts with ZRANB1 and extends its protein half-life by more than twofold, supported by co-immunoprecipitation findings.\"},{\"question\":\"How is ferroptosis regulated in relation to UCHL5?\",\"answer\":\"Overexpression of UCHL5 increases sensitivity to erastin, whereas knockout provides protection. This correlates with altered GSH levels, Fe2+ accumulation, and lipid ROS production, along with changes in ZRANB1 and SLC7A11/GPX4 expression.\"}]","UCHL5 suppresses thyroid carcinoma progression via ZRANB1 stabilization and ferroptosis regulation | PDF",1790120064,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93e10190f641a1b74e9619f8304296bb.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07281b68192e297abeeb2ac57081c8dc.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fe157880890fe67445d1fdbbc4616a6.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/015891def0d4b8a2a8ea107cfd872945.webp",980,1306]